Table 1.

Somatic Growth at P14

	RA				IH
	Topical ocular		Oral		Topical ocular		Oral
	Saline	Prop	Saline	Prop	Saline	Prop	Saline	Prop
% Change body wt. (P0–P14)	252.6 ± 14.9	208.8 ± 14.9**	286.2 ± 7.8#	258.9 ± 14.8#	252.0 ± 18.8	159.3 ± 18.2**#	214.5 ± 18.2§§	244.9 ± 10.8##§§
% Change length (P0–P14)	57.1 ± 2.1	35.7 ± 8.5**	54.6 ± 2.7	53.5 ± 2.4##	55.5 ± 6.6	36.3 ± 3.7**	55.4 ± 2.6	61.1 ± 2.4##§
Brain/body wt. ratio	0.046 ± 0.002	0.049 ± 0.0016	0.047 ± 0.001	0.044 ± 0.006	0.044 ± 0.001	0.05 ± 0.004	0.049 ± 0.003	0.044 ± 0.001
Heart/body wt. ratio	0.006 ± 0.0003	0.006 ± 0.0005	0.007 ± 0.0003	0.007 ± 0.007	0.007 ± 0.0003	0.007 ± 0.0007	0.007 ± 0.0005	0.006 ± 0.0003
Lung/body wt. ratio	0.018 ± 0.0009	0.018 ± 0.0009	0.018 ± 0.0001	0.02 ± 0.001**	0.018 ± 0.0007	0.024 ± 0.001**	0.018 ± 0.001	0.019 ± 0.001##§§
Liver/body wt. ratio	0.028 ± 0.001	0.027 ± 0.002	0.027 ± 0.0009	0.028 ± 0.003	0.028 ± 0.002	0.028 ± 0.002	0.03 ± 0.002	0.03 ± 0.001
Kidney/body wt. ratio	0.013 ± 0.0005	0.013 ± 0.0007	0.014 ± 0.0007	0.014 ± 0.001	0.014 ± 0.0005	0.014 ± 0.001	0.015 ± 0.0004	0.014 ± 0.0005

^*P < 0.05, ^**P < 0.01 saline versus propranolol; ^#P < 0.05, ^##P < 0.01 topical ocular versus oral; ^§P < 0.05, ^§§P < 0.01 RA versus IH (n = 18 pups/group).

IH, intermittent hypoxia; Prop, propranolol; RA, room air; Wt., weight.